Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-032252

Executive VP, Global R&D sold 19,066 shares at $10.22 ($194,830)

  • Executive VP, Global R&D acquired 37,884 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fridriksdottir Hafrun Executive VP, Global R&D 2021-05-11 Option exercise +37,884 111,337.51 D
Fridriksdottir Hafrun Executive VP, Global R&D 2021-05-11 Sale −19,066 $10.22 $194,830 92,271.51 D
Derivatives
Fridriksdottir Hafrun Executive VP, Global R&D 2021-05-11 Option exercise · Restricted Share Units −37,884 0 D
Open-market sales · 19,066 sh · avg $10.22 · $194,830
Loading xslF345X03/doc4.xml…